DIGITAL-VAULT-SERVICES
15.4.2024 09:01:30 CEST | Business Wire | Press release
Digital Vault Services:
- Siemens chooses Digital Vault Services (DVS) for guarantee digitization.
- Collaboration with Digital Vault Services reflects Siemens commitment to innovation and efficiency.
- DVS’s Guarantee Vault Platform enables Siemens to optimize workflow efficiency and enhance security in guarantee management.
Siemens, a technology company focused on industry, infrastructure, transport, and healthcare, chooses Digital Vault Services for guarantee digitization, reflecting its dedication to innovation and efficiency. Through the integration of Digital Vault Services' innovative Guarantee Vault Platform (GVP), Siemens propels its digital transformation journey within its Guarantee Business, leveraging technology to optimize operations and enhance customer satisfaction.
The adoption of the Guarantee Vault will empower Siemens for streamlined and digitized guarantee processes. With GVP integrated into its operations, Siemens will benefit from GVP’s unchallenged capabilities to seamlessly connect to the entire guarantee ecosystem including all bank and insurance partners.
Gerhard Heubeck, Global Head Trade Finance Advisory at Siemens, commented, “We are pleased to announce our partnership with Digital Vault Services. As an active member of the working group, we have always been convinced of GVP's capabilities to significantly improve our collaboration and communication with our financial partners and to eliminate time-consuming, manual and paper-based processes. By leveraging GVP's innovative features, we can now engage in efficient, fast, and paperless interactions, while fully digitizing the end-to-end process from our organization through our financial partners to our valued customers. “
"We are thrilled to collaborate with Siemens, a key member of the working group that contributed to the development of our Guarantee Vault Platform," said Ludger Janßen, Co-CEO of Digital Vault Services. "Siemens commitment to innovation aligns perfectly with our mission to digitize the entire guarantee ecosystem and helps with the digital transformation of the financial industry. Together, we will drive significant advancements in guarantee processing efficiency and security."
Jaime Gimeno, Co-CEO of Digital Vault Services added: "With digital guarantees issued, secured and safekept on Guarantee Vault, Siemens and its customers are well positioned to achieve maximum efficiency and transparency. We do all this using best in class technology secured to ISO 27001 standards to keep our customers safe. We welcome Siemens to our network and look forward to working with them on their digitization journey."
About Digital Vault Services
Digital Vault Services GmbH revolutionizes the guarantee journey with its Guarantee Vault, boosting complete digitization. This solution offers a seamless, paperless experience, transforming the guarantee ecosystem end to end. Applicants can request all types of guarantees globally within one central tool, while banks and insurers securely issue and store guarantees. Beneficiaries enjoy seamless interaction and can manage and access the guarantees anytime. Innovative features such as beneficiary read confirmation and pre-approved wording libraries enhance processing speed, transparency, and efficiency. With top-tier security standards and API integration for seamless connectivity, DVS ensures a robust solution for all guarantee- business needs.
Founded in 2018 through collaboration with 16 industry participants, banks and insurers, Digital Vault Services has rapidly evolved. Since its launch in 2021, Guarantee Vault has gained strong traction in Germany and is now expanding into other European markets, including the Nordic countries, where future presence has already been announced. The company’s headquarters are located in Munich, Germany.
About Siemens
Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, transport, and healthcare. From more resource-efficient factories, resilient supply chains, and smarter buildings and grids, to cleaner and more comfortable transportation as well as advanced healthcare, the company creates technology with purpose adding real value for customers. By combining the real and the digital worlds, Siemens empowers its customers to transform their industries and markets, helping them to transform the everyday for billions of people. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a globally leading medical technology provider shaping the future of healthcare. In fiscal 2023, which ended on September 30, 2023, the Siemens Group generated revenue of €77.8 billion and net income of €8.5 billion. As of September 30, 2023, the company employed around 320,000 people worldwide. Further information is available on the Internet at www.siemens.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240412273459/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Together AI and HUMAIN Form Strategic Partnership to Accelerate AI Infrastructure and Cloud Services in Saudi Arabia31.8.2026 14:00:00 CEST | Press release
The partnership, which was announced on stage at LEAP, Combines HUMAIN’s AI Infrastructure Foundation with Together’s AI Native Cloud Platform and Global Reach Together AI, a leading San Francisco-based AI Native Cloud platform, and HUMAIN, a PIF company delivering full-stack artificial intelligence capabilities globally, today at LEAP announced a strategic partnership to connect HUMAIN’s rapidly expanding AI compute capacity in Saudi Arabia with global AI-native and enterprise demand. The partnership will include the construction of a new 250 megawatt data center, located in Saudi Arabia. The partnership brings together HUMAIN’s large-scale, multi-chip AI infrastructure footprint, expanding cloud and inference capabilities with Together AI’s global customer ecosystem and AI-native inference platform. Together, the companies will offer an additional option for developers, enterprises, and AI-native organizations worldwide to access high-performance AI infrastructure for inference and t
SLB to Acquire Kelvion, Expanding its Role Across Data Center Infrastructure31.8.2026 12:50:00 CEST | Press release
Scalable, energy-efficient and reliable thermal management technologies will optimize operating performance in increasingly complex data centers and industrial systems SLB (NYSE: SLB) today announced it has signed an agreement to acquire Kelvion, a global provider of thermal management and heat exchange technologies. The acquisition strengthens SLB's Data Center Solutions business with critical thermal management technologies and expands the company's role in data center infrastructure, which is one of the world’s fastest-growing industrial and technology markets. “AI is driving the most significant infrastructure investment cycle in our lifetime,” said Olivier Le Peuch, chief executive officer of SLB. “This transaction accelerates our ambition to become an industrial technology partner to the data center industry and help customers address the growing infrastructure complexity required to scale AI. Kelvion advances our path toward more integrated data center infrastructure solutions,
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 12:00:00 CEST | Press release
Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA
GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 09:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom